Cargando…

Identification of gaps in the current allergic rhinitis guidelines and how these can be filled

Detalles Bibliográficos
Autores principales:	Bousquet, Jean, Bachert, Claus, Mösges, Ralph, Fokkens, Wytske, Hellings, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493615/ http://dx.doi.org/10.1186/2045-7022-5-S4-P39

Ejemplares similares

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
por: Fokkens, Wytske, et al.
Publicado: (2015)

Quality of life and use of medication in chronic allergic and non-allergic rhinitis patients
por: Segboer, Christine, et al.
Publicado: (2013)

New insights into the pathogenesis of non-allergic rhinitis
por: Segboer, Christine, et al.
Publicado: (2015)

A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
por: Bachert, Claus, et al.
Publicado: (2015)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment
por: Hoffmans, Ruth, et al.
Publicado: (2018)

Capsaicin for Rhinitis
por: Fokkens, Wytske, et al.
Publicado: (2016)

Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management
por: Bachert, C., et al.
Publicado: (2018)

Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity
por: Hoffmans, Ruth, et al.
Publicado: (2015)

Direct and indirect costs of allergic and non‐allergic rhinitis in the Netherlands
por: Avdeeva, Klementina S., et al.
Publicado: (2020)

Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine
por: Mullol, Joaquim, et al.
Publicado: (2005)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report
por: Cingi, C., et al.
Publicado: (2017)

ARIA guideline 2019: treatment of allergic rhinitis in the German health system
por: Klimek, Ludger, et al.
Publicado: (2019)

Endotyping of non-allergic, allergic and mixed rhinitis patients using a broad panel of biomarkers in nasal secretions
por: Segboer, Christine L., et al.
Publicado: (2018)

Thoughts on the pathophysiology of nonallergic rhinitis
por: Fokkens, Wytske J.
Publicado: (2002)

The prevalence of non‐allergic rhinitis phenotypes in the general population: A cross‐sectional study
por: Avdeeva, Klementina S., et al.
Publicado: (2022)

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis
por: Mösges, Ralph, et al.
Publicado: (1995)

Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity
por: D’Addio, Alex, et al.
Publicado: (2015)

The Effectiveness of the Bacteria Derived Extremolyte Ectoine for the Treatment of Allergic Rhinitis
por: Bilstein, Andreas, et al.
Publicado: (2021)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

P07 - Treatment load in the therapy management of allergic rhinitis: a UK retrospective database study
por: Carter, Victoria, et al.
Publicado: (2014)

Observational study: evaluating symptom control in allergic rhinitis at three years after starting immunotherapy
por: Droessaert, Valerie, et al.
Publicado: (2013)

Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China
por: Lou, Hongfei, et al.
Publicado: (2017)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

The Impact of Allergic Rhinitis and Asthma on Human Nasal and Bronchial Epithelial Gene Expression
por: Wagener, Ariane H., et al.
Publicado: (2013)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

A Model for the Determination of Pollen Count Using Google Search Queries for Patients Suffering from Allergic Rhinitis
por: König, Volker, et al.
Publicado: (2014)

Subjects with local allergic rhinitis can be identified by basophil activation test
por: Campo, Paloma, et al.
Publicado: (2013)

Seasonal distribution of inhaled allergens in allergic asthma patients with or without allergic rhinitis
por: Tian, Ruxian, et al.
Publicado: (2022)

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
por: Hox, Valerie, et al.
Publicado: (2020)

Clinical Characteristics of Allergic Rhinitis According to Allergic Rhinitis and Its Impact on Asthma Guidelines
por: Lee, Chul Hee, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c3p5b5p3942k0mcl19c4nrjtn0